Compare Definium Therapeutics Inc. Common Shares (DFTX) vs Harley-Davidson Inc (HOG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Definium Therapeutics Inc. Common Shares vs Harley-Davidson Inc — how do they compare? Definium Therapeutics Inc. Common Shares trades at $34.01 (market cap $4.71B), while Harley-Davidson Inc trades at $26.75 (market cap $2.80B). The key difference: Definium Therapeutics Inc. Common Shares is the larger of the two by market cap, and Harley-Davidson Inc pays a 2.78% dividend while Definium Therapeutics Inc. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and Harley-Davidson Inc for 91 Days on average.
| DFTX | HOG | |
|---|---|---|
Market Cap | $4.71B | $2.80B |
Volume | 1,966,636 | 2,093,216 |
Sector | Health | Consumer Cyclical |
52-Week High | $48.45 | $28.46 |
52-Week Low | $10.68 | $17.19 |
Typical Hold Time | 0 Days | 91 Days |
Enterprise Value | $3.67B | $3.22B |
Dividend Yield | — | 2.78% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Harley-Davidson (HOG) trades at $26.75, down 0.71% on the day, with a bullish technical signal and mixed earnings history. The stock shows attractive valuation ratios, including a P/E of 14.97 and P/S of 0.72, but faces declining revenue and net income margins. Recent news highlights tariff exposure and a data breach, while analyst consensus is a 'Hold' with a $28.50 price target. Cash flow trends are volatile, with 2025 showing a net inflow of $1.35 billion driven by investing activities.
The outlook for HOG is cautious due to fundamental pressures, including falling profitability and revenue, offset by low valuations and a dividend. Key risks include competitive threats and sensitivity to tariffs. Upside potential exists if the 'Back to the Bricks' strategy revives growth, but investors should weigh margin erosion against valuation support.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Definium Therapeutics Inc. Common Shares
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →About Harley-Davidson Inc
Harley-Davidson is a global leading manufacturer of heavyweight motorcycles, merchandise, parts, and accessories. It sells custom, cruiser, and touring motorcycles and offers a complete line of Harley-Davidson motorcycle parts, accessories, riding gear, and apparel, as well as merchandise. Harley-Davidson Financial Services provides wholesale financing to dealers and retail financing and insurance brokerage services to customers. Harley has historically captured about half of all heavyweight domestic retail motorcycle registrations, a metric it had ceded in 2020 as it repositioned the business, but a level it is working back toward. In recent years the firm has expanded into the adventure touring market with its Pan America model and into electric with the LiveWire brand.
Read more on HOG →
